original ) (raw )Theprognostic significance of humanchorionic gonadotrophin andits metabolites inwomen with
Ray Iles
1998
View PDFchevron_right
Free Human Chorionic Gonadotropin ß Subunit in Gonadal and Nongonadal Neoplasms1
Dominique Bellet
View PDFchevron_right
Elevated beta human chorionic gonadotropin in a non-pregnant female diagnosed with anal squamous cell carcinoma
Peter Gilbar
Journal of Oncology Pharmacy Practice
View PDFchevron_right
Serum tumour markers in gynaecological cancers
Sean Kehoe
Maturitas, 2010
View PDFchevron_right
The prognostic significance of beta human chorionic gonadotrophin and its metabolites in women with cervical carcinoma
John Shepherd
Journal of Clinical Pathology, 1998
View PDFchevron_right
Chorionic Gonadotropin β-Subunit and Core Fragment in Bladder Cancer: mRNA and Protein Expression in Urine, Serum and Tissue
Ulf-Håkan Stenman
European Urology, 2002
View PDFchevron_right
Human chorionic gonadotropin in serum and neoplastic tissue from patients with bladder carcinoma
Sak Sak
International Urology and Nephrology, 1995
View PDFchevron_right
Immunohistochemistry: A Valuable Tool in the Management of Common Female Genital Tract Tumors—A Clinicians’ Perspective
Rajesh Panicker
2021
View PDFchevron_right
Molecular heterogeneity of human chorionic gonadotropin in serum and urine from patients with trophoblastic tumors
Rudolf Hoermann
The Clinical investigator, 1993
View PDFchevron_right
Free -Subunit of Human Chorionic Gonadotropin in Serum Is a Diagnostically Sensitive Marker of Seminomatous Testicular Cancer
Anna Lempiäinen , Ulf-Håkan Stenman
Clinical Chemistry, 2008
View PDFchevron_right
Discordance of human chorionic gonadotropin and alpha-fetoprotein in testicular teratocarcinomas
Glenn Braunstein
Cancer, 1973
View PDFchevron_right
Serum tumor marker immunoassays in gynecologic oncology: Establishment of reference values
Peter Kenemans
American Journal of Obstetrics and Gynecology, 1996
View PDFchevron_right
Prospective study of the α and β subunits of human chorionic gonadotrophin in the blood of patients with various benign and malignant conditions
Anna Stolarczyk
1965
View PDFchevron_right
The free β-subunit of human chorionic gonadotropin as a prognostic factor in renal cell carcinoma
Ulf-Håkan Stenman
British Journal of Cancer
View PDFchevron_right
Human Chorionic Gonadotropin as a Biomarker not only Pregnant Women, but also as a Marker in Men – Testicular Cancer – Review and Case Report
united prime
Annals of Cinical and Medical Case Reports, 2024
View PDFchevron_right
Expression of the free ?-subunit of human chorionic gonadotropin in renal cell carcinoma: Prognostic study on tissue and serum
Ulf-Håkan Stenman
International Journal of Cancer, 2003
View PDFchevron_right
Diurnal variation of urinary "hCG beta subunit core fragment" production evaluated in patients with gynecological neoplasms
John Shepherd
Clinical Chemistry, 1994
View PDFchevron_right
Immunoreactive human chorionic gonadotropin and its free beta subunit in serum and ascites of patients with malignant tumors
Rudolf Hoermann
Cancer research, 1992
View PDFchevron_right
Serum tumor markers in the management of ovarian, endometrial and cervical cancer
Stefania Cosio
Biomedicine & Pharmacotherapy, 2004
View PDFchevron_right
Serum β-human chorionic gonadotropin as a tumor marker for malignant mesothelioma
Burcak Erkol
2016
View PDFchevron_right
Hematologic malignancies of the female genital tract diagnosed on liquid-based Pap test: Cytomorphologic features and review of differential diagnoses
George Birdsong
Diagnostic Cytopathology, 2009
View PDFchevron_right
Serum in cervical cancer patients
Engelbert Hanzal
European Journal of Cancer, 1997
View PDFchevron_right
Detection of Human Chorionic Gonadotrophin-β in Serum or Urine of Prostate Cancer Patients Is of No Clinical Significance
Frank Chinegwundoh
Tumor Biology, 2006
View PDFchevron_right
A step forward in identifying the right human chorionic gonadotropin assay for testicular cancer
Simona Ferraro
Clinical Chemistry and Laboratory Medicine (CCLM), 2019
View PDFchevron_right
Serum concentrations of squamous-cell carcinoma antigen and tissue polypeptide antigen in the follow-up of patients with vulvar cancer
Alexander Reinthaller
International Journal of Cancer, 1999
View PDFchevron_right
Early Diagnosis of Gynecological Cancers in Ladies with Review of Literature
Tanushri Mukherjee
Open Journal of Obstetrics and Gynecology
View PDFchevron_right
Coexpression of human chorionic gonadotropin beta subunit and its receptor in nontrophoblastic gynecological cancer
Mirosław Andrusiewicz
International Journal of Gynecological Cancer, 2008
View PDFchevron_right
Gynecologic Tumor Markers Tumor Marker Overview
Fazal Hussain, MD, MPH
View PDFchevron_right
Koilocytosis: Correlations with high-risk HPV and its comparison on tissue sections and cytology, urothelial carcinoma
Arati Bhatia
Diagnostic Cytopathology, 2009
View PDFchevron_right
Substantial urinary concentrations of material resembling beta-core fragment of chorionic gonadotropin beta-subunit in mid-menstrual cycle
Ray Iles
Clinical chemistry, 1993
View PDFchevron_right
Unusual Manifestation of Ectopic Human Chorionic Gonadotropin-Producing Cancers
BJSTR Angela Roy
BJSTR, 2022
View PDFchevron_right
Biochemical markers in the plasma and tumors of patients with gynecologic malignancies
Edward Pavlik
Cancer, 1981
View PDFchevron_right
Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: Correlation between two laboratories and preliminary clinical results
Lee Manchul
International Journal of Radiation Oncology*Biology*Physics, 1995
View PDFchevron_right